ZMYND8 and breast carcinoma: CCK-8 assays revealed no statistically significant difference in proliferative activity between ZMYND8-knockout breast cancer cells (ZMYND8-sg1, ZMYND8-sg2) and the control group (Ctrl) (Fig. 3B).